DK2800581T3 - Fremgangsmåder til behandling af adfærdssymptomer på neurologiske og mentale forstyrrelser - Google Patents
Fremgangsmåder til behandling af adfærdssymptomer på neurologiske og mentale forstyrrelser Download PDFInfo
- Publication number
- DK2800581T3 DK2800581T3 DK13733621.0T DK13733621T DK2800581T3 DK 2800581 T3 DK2800581 T3 DK 2800581T3 DK 13733621 T DK13733621 T DK 13733621T DK 2800581 T3 DK2800581 T3 DK 2800581T3
- Authority
- DK
- Denmark
- Prior art keywords
- neurological
- approaches
- treatment
- mental disorders
- behavioral symptoms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Closures For Containers (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261582813P | 2012-01-03 | 2012-01-03 | |
| US201261600110P | 2012-02-17 | 2012-02-17 | |
| PCT/US2013/020183 WO2013103746A1 (en) | 2012-01-03 | 2013-01-03 | Methods of treating behavioral symptoms of neurological and mental disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2800581T3 true DK2800581T3 (da) | 2024-06-17 |
Family
ID=48745413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13733621.0T DK2800581T3 (da) | 2012-01-03 | 2013-01-03 | Fremgangsmåder til behandling af adfærdssymptomer på neurologiske og mentale forstyrrelser |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20130224172A1 (enExample) |
| EP (1) | EP2800581B1 (enExample) |
| JP (3) | JP6796372B2 (enExample) |
| KR (3) | KR20190109564A (enExample) |
| CN (2) | CN104144698A (enExample) |
| AU (2) | AU2013206890B2 (enExample) |
| BR (1) | BR112014016557A8 (enExample) |
| CA (1) | CA2862403C (enExample) |
| DK (1) | DK2800581T3 (enExample) |
| GB (1) | GB2511713B (enExample) |
| HK (1) | HK1257360A1 (enExample) |
| IL (1) | IL233372B (enExample) |
| MX (2) | MX363096B (enExample) |
| NZ (2) | NZ737957A (enExample) |
| RU (1) | RU2654230C2 (enExample) |
| WO (1) | WO2013103746A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070053895A1 (en) | 2000-08-14 | 2007-03-08 | Fallon Joan M | Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
| US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
| US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
| US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
| US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
| US9320780B2 (en) | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
| PL2318035T3 (pl) | 2008-07-01 | 2019-10-31 | Curemark Llc | Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego |
| US10776453B2 (en) | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
| US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
| CA2747703C (en) | 2009-01-06 | 2021-06-15 | Curemark Llc | Compositions and methods for the treatment or the prevention of infections by e. coli |
| JP5684725B2 (ja) | 2009-01-06 | 2015-03-18 | キュレロン リミテッド ライアビリティ カンパニー | 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法 |
| US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
| US9511125B2 (en) | 2009-10-21 | 2016-12-06 | Curemark Llc | Methods and compositions for the treatment of influenza |
| DK2701733T3 (da) | 2011-04-21 | 2019-05-27 | Curemark Llc | Forbindelser til behandling af neuropsykiatriske forstyrrelser |
| US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
| US10813901B2 (en) | 2013-10-22 | 2020-10-27 | Yamo Pharmaceuticals Llc | Compositions and methods for treating autism |
| AU2016247301A1 (en) * | 2015-04-14 | 2017-10-26 | Steven Hoffman | Compositions and methods for treating autism |
| CN105213433A (zh) * | 2015-11-06 | 2016-01-06 | 王益超 | 一种用于治疗孤独症、复发性流产和不孕症的组合物 |
| WO2018191233A1 (en) | 2017-04-10 | 2018-10-18 | Curemark, Llc | Compositions for treating addiction |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| US11547707B2 (en) * | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| US20210043106A1 (en) * | 2019-08-08 | 2021-02-11 | COGNITIVEBOTICS Technologies Pvt. Ltd. | Technology based learning platform for persons having autism |
| US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
| CN112347257B (zh) * | 2020-11-11 | 2024-07-09 | 北京嘉和海森健康科技有限公司 | 一种患者症状口语化标准化方法和装置 |
| WO2023201358A2 (en) * | 2022-04-15 | 2023-10-19 | AEON Biopharma, Inc. | Neurotoxin compositions for use in regulating brain temperature |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1509866A (en) * | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
| US6632429B1 (en) * | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
| US6534063B1 (en) * | 1999-12-17 | 2003-03-18 | Joan M. Fallon | Methods for treating pervasive development disorders |
| US6251478B1 (en) | 1999-12-22 | 2001-06-26 | Balchem Corporation | Sensitive substance encapsulation |
| US6261613B1 (en) | 2000-02-15 | 2001-07-17 | General Mills, Inc. | Refrigerated and shelf-stable bakery dough products |
| US6399114B2 (en) * | 2000-05-26 | 2002-06-04 | C & D Foreman, Inc. | Nutritional system for nervous system disorders |
| US6660831B2 (en) | 2000-08-14 | 2003-12-09 | Joan M. Fallon | Method for diagnosing and treating dysautonomia and other dysautonomic conditions |
| DE10065123B4 (de) * | 2000-12-28 | 2012-12-20 | Robert Bosch Gmbh | Verfahren zur Steuerung einer Diagnose eines Katalysators im Abgas eines Verbrennungsmotors |
| AU2002364750A1 (en) * | 2001-12-14 | 2003-06-30 | Solvay Pharmaceuticals Gmbh | Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans |
| CA2560613C (en) * | 2004-03-22 | 2015-11-24 | Solvay Pharmaceuticals Gmbh | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
| US20060115467A1 (en) * | 2004-12-01 | 2006-06-01 | Pangborn Jon B | Compositions and methods for the treatment of autism |
| PL2318035T3 (pl) | 2008-07-01 | 2019-10-31 | Curemark Llc | Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego |
| US9056050B2 (en) * | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
| JP5914357B2 (ja) * | 2010-01-15 | 2016-05-11 | インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル） | 自閉症の治療のための化合物 |
-
2013
- 2013-01-03 KR KR1020197026879A patent/KR20190109564A/ko not_active Ceased
- 2013-01-03 WO PCT/US2013/020183 patent/WO2013103746A1/en not_active Ceased
- 2013-01-03 GB GB1411821.0A patent/GB2511713B/en active Active
- 2013-01-03 CN CN201380012401.2A patent/CN104144698A/zh active Pending
- 2013-01-03 DK DK13733621.0T patent/DK2800581T3/da active
- 2013-01-03 NZ NZ737957A patent/NZ737957A/en unknown
- 2013-01-03 EP EP13733621.0A patent/EP2800581B1/en active Active
- 2013-01-03 AU AU2013206890A patent/AU2013206890B2/en active Active
- 2013-01-03 US US13/733,873 patent/US20130224172A1/en not_active Abandoned
- 2013-01-03 JP JP2014551323A patent/JP6796372B2/ja active Active
- 2013-01-03 CA CA2862403A patent/CA2862403C/en active Active
- 2013-01-03 NZ NZ716627A patent/NZ716627A/en unknown
- 2013-01-03 CN CN201810356485.6A patent/CN108578684A/zh active Pending
- 2013-01-03 KR KR1020207027464A patent/KR102315761B1/ko active Active
- 2013-01-03 RU RU2014130165A patent/RU2654230C2/ru active
- 2013-01-03 BR BR112014016557A patent/BR112014016557A8/pt not_active Application Discontinuation
- 2013-01-03 MX MX2014008156A patent/MX363096B/es unknown
- 2013-01-03 KR KR1020147021425A patent/KR20140107665A/ko not_active Ceased
-
2014
- 2014-06-25 IL IL233372A patent/IL233372B/en active IP Right Grant
- 2014-07-02 MX MX2019002669A patent/MX2019002669A/es unknown
-
2017
- 2017-09-19 AU AU2017232048A patent/AU2017232048B2/en active Active
-
2018
- 2018-08-17 JP JP2018153357A patent/JP6810724B2/ja active Active
- 2018-12-25 HK HK18116568.8A patent/HK1257360A1/zh unknown
-
2020
- 2020-08-03 US US16/983,352 patent/US20210162024A1/en not_active Abandoned
- 2020-10-01 JP JP2020166691A patent/JP2021001222A/ja active Pending
-
2025
- 2025-11-18 US US19/392,513 patent/US20260069667A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL233372A0 (en) | Methods of treating behavioral symptoms of neurological and mental disorders | |
| DK2838539T3 (da) | Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser | |
| LT2796132T (lt) | Neurologinių sutrikimų terapija baklofeno ir akamprosato pagrindu | |
| IL244677A0 (en) | Compositions useful for treating disorders related to kit | |
| DK2981269T3 (da) | Behandling af stofskifteforstyrrelser hos hestedyr | |
| SI2707029T1 (sl) | Metode zdravljenja ali preprečevanja s holesterolom povezanih motenj | |
| LT2882441T (lt) | Su imunitetu susijusių ir uždegiminių ligų gydymas | |
| IL239355A0 (en) | Compositions of gamma-hydroxybutyrate and their use in the treatment of disorders | |
| EP2983657A4 (en) | TREATMENT OF GASTROINTESTINAL AND OTHER DISEASES | |
| DK2877184T3 (da) | Sammensætninger og behandling for øjensygdomme og -lidelser | |
| EP2906208A4 (en) | THERAPEUTIC TREATMENT | |
| HRP20180337T1 (hr) | Kalcitonin mimetika za liječenje bolesti i poremećaja | |
| IL284347A (en) | Geranium oil and constituents thereof for treatment of neurodegenerative diseases | |
| IL225668A (en) | Formulations for the treatment of disorders of the upper respiratory tract | |
| EP2869833A4 (en) | TREATMENT OF INFLAMMATORY SKIN DISORDERS | |
| HUE037179T2 (hu) | Gyógyászati kompozíciók izom-rendellenességek kezelésére | |
| DK3003366T3 (da) | På hinanden følgende overlappende peptider til behandling af allergi overfor husstøvmider | |
| HRP20181481T1 (hr) | D-metadon za liječenje psihijatrijskih simptoma | |
| IL234606B (en) | Novel methods and composition for treatment of disease | |
| LTPA2020511I1 (lt) | Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui | |
| DK2830645T3 (da) | Neuregulin til anvendelse i behandling af perifær nervelæsion | |
| EP2887947A4 (en) | TREATMENT OF ACIDIC ACID AND INFLAMMATORY DISEASES | |
| DK2892556T3 (da) | Sammensætninger og fremgangsmåder til behandling af sygdomme | |
| ZA201507724B (en) | The treatment of inflammatory disorders | |
| HUE045148T2 (hu) | Bumetanid parkinson-szindrómás neurodegeneratív betegségek kezelésére |